HC Wainwright Issues Pessimistic Outlook for SABS Earnings

Дата публикации: 10-08-2026 05:44:44

SAB Biotherapeutics, Inc. (NASDAQ:SABS – Free Report) – HC Wainwright decreased their Q3 2026 earnings estimates for shares of SAB Biotherapeutics in a research report issued to clients and investors on Thursday, August 6th. HC Wainwright analyst E. Bodnar now expects that the company will earn ($0.29) per share for the quarter, down from their […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Q3 EPS Estimate for SAB Biotherapeutics Boosted by Analyst	0	11.83	10-08-2026
2	Q3 EPS Estimates for CG Oncology Lowered by HC Wainwright	0	11.48	10-08-2026
3	HC Wainwright Issues Optimistic Estimate for CNTX Earnings	0	12.95	10-08-2026
4	Research Analysts Offer Predictions for CMPX Q3 Earnings	0	11.48	10-08-2026
5	HC Wainwright Issues Pessimistic Estimate for ARWR Earnings	0	13.33	10-08-2026
6	HC Wainwright Has Weak Forecast for Cytosorbents Q1 Earnings	0	11.13	10-08-2026
7	What is HC Wainwright’s Estimate for PTGX FY2026 Earnings?	0	13.4	10-08-2026
8	Analysts Issue Forecasts for Energy Fuels FY2026 Earnings	0	13.04	10-08-2026
9	Energy Fuels FY2026 EPS Estimate Reduced by HC Wainwright	0	13.4	10-08-2026
10	FY2029 Earnings Forecast for IN8bio Issued By HC Wainwright	0	14.81	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.58. Источник: www.americanbankingnews.com.